Adjuvant Capital

New York, New York · Venture Capital

About

Adjuvant Capital is a life sciences venture firm based in New York and San Francisco that backs drugs, vaccines, diagnostics and devices for global public health challenges. It manages about $300m, with limited partners including the Bill & Melinda Gates Foundation, Novartis and the International Finance Corporation. Its focus spans infectious disease, maternal and child health and antimicrobial resistance.

Stage focus

Request removal →

Raising from Adjuvant Capital?

I've worked with founders across the industrial stack. If Adjuvant Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.

Talk to Dan